drugset
drugset / Trial / NCT03602066

Study Evaluating The Role of ClO2 on Mucositis for Pt. Undergoing Head/Neck Radiotherapy

NCT03602066 ↗

Phase 2 Terminated 14 enrolled University of Arizona National Cancer Institute (NCI) · collab
RandomizedParallel-groupDouble-blindSupportive care

Summary

This pilot randomized phase II trial studies who well chlorine dioxide sterilization works in reducing oral mucositis in patients with stage I-IV head and neck cancer who are undergoing radiotherapy. Chlorine dioxide sterilization may help to treat oral mucositis.

Timeline

Start
2019-02-14
Primary completion
2022-11-07
Completion
2022-11-07

Drugs

EvaluationDrugModalityDoseRoute
Subject chlorine dioxide Unknown — Oral

Indications

head and neck carcinoma